The Gene-Eden-VIR/Novirin formula was developed to target latent viruses including the HSV, HPV, CMV, EBV and HCV, and diminish their effect on the infected individual.

Gene-Eden-VIR was launched at the end of 2009, and Novirin in 2014. Gene-Eden-VIR and Novirin have the same formula.
The difference between the two products is that Novirin has higher quality, more expensive ingredients.

Many doctors prescribe Gene-Eden-VIR to their patients.
See, for instance, the following four prescriptions for Gene-Eden-VIR (some information was blacked out to protect the privacy of the people involved).

&nbsp&nbsp&nbsp&nbsp

&nbsp&nbsp&nbsp&nbsp

Discreet and Confidential

Many people are infected with latent viruses. However, most of them don't want others to know about it.
An infection is a private matter, and most people would like their infection to remain confidential. To protect your privacy, we do the following:

1. Shipping: We will always ship your order in a plain discrete envelope. The envelope has no
external packing list, and no indication of its content.

2. Label: The label on the bottle does not mention the words Herpes, HPV, or any other virus, or disease.
If asked, you can easily and truthfully say that you take Gene-Eden-VIR to boost your immune system.

Gene-Eden-VIR/Novirin takes 4-6 weeks to show results. Unlike some drugs, the changes are gradual, and can be easily missed.

Stopping Gene-Eden-VIR/Novirin is not recommended since the symptoms may return or get worse.

Gene-Eden-VIR/Novirin has no side effects (see clinical studies below), and therefore, is suitable for long term use.

One bottle of Gene-Eden-VIR/Novirin contains 60 capsules. The recommended dose is 2 capsules per day. Therefore, 1 bottle will last for 1 month.
To see an improvement, it is recommended to take at least 2 bottles of Gene-Eden-VIR/Novirin.

The Center for the Biology of Chronic Disease (CBCD) published the first clinical study of
Gene-Eden-VIR/Novirin in 2013. The study was published in the medical journal Pharmacoloy and Pharmacy.
The study showed that Gene-Eden-VIR/Novirin has antiviral properties. According to the study: "...the clinical study showed that Gene-Eden-VIR is a safe and effective treatment against the Human Papillomavirus (HPV),
Herpes Simplex Virus (HSV), Epstein Barr Virus (EBV), Human Cytomegalovirus (HCMV), and Hepatitis C Virus (HCV).
Therefore, health care practitioners should recommend Gene-Eden-VIR as a safe and effective antiviral treatment against these viruses."
(Click here to read the full study.)

The CBCD published a second clinical study in 2014.
The study was also published in the medical journal Pharmacoloy and Pharmacy.
This study showed that Gene-Eden-VIR/Novirin safely decreased the feeling of
fatigue in individuals infected with a latent virus.
According to the study: "...health care practitioners should recommend Gene-Eden-VIR as a first line treatment for fatigue."
(Click here to read the full study.)

A third clinical study was published in the medical journal
Drug Design, Development and Therapy on August 29, 2016.
This study showed that Gene-Eden-VIR/Novirin decreased the number of genital herpes outbreaks without any side effects.
It also showed that Gene-Eden-VIR/Novirin is better than acyclovir,
valacyclovir, and famciclovir, the three leading antiviral drugs.
According to the study: "The clinical study showed that the natural Gene-Eden-VIR/Novirin decreases the number of genital herpes outbreaks without any side effects.
The study also showed that the clinical effects reported in this study are mostly better than those reported in the reviewed studies of acyclovir, valacyclovir, and famciclovir."
(Click here to read the full study.)

A fourth clinical study was published in the medical journal Clinical and Translational Medicine on October 20, 2016.
The study showed that Gene-Eden-VIR/Novirin safely decreased the duration of genital herpes outbreaks in both severe and mild cases.
According to the study: "Based on the results reported in this and our previous paper, we recommend suppressive treatment with Gene-Eden-VIR/Novirin as a natural alternative
to both suppressive and episodic treatments with current drugs, in both severe and mild genital herpes cases."
(Click here to read the full study.)

A fifth clinical study was published in the medical journal Drug Design, Development and Therapy on March 3, 2017.
The study showed that Gene-Eden-VIR/Novirin cleared the human papillomavirus (HPV)
in individuals suffering from a symptomatic HPV infection without any adverse effects.
(Click here to read the full study.)

Gene-Eden-VIR has been in the market for more than seven years.
Thousands of people around the world take Gene-Eden-VIR or Novirin daily.
These people are so happy with the effects of Gene-Eden-VIR/Novirin on their health,
that some take it on a regular basis for over seven years now.

Gene-Eden-VIR

90 Days Money-Back

Guarantee

Are you still hesitating?
We suggest you try Gene-Eden-VIR.
If you are unhappy, for any reason, return the Gene-Eden-VIR bottles,
and we will refund your money.